Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes.

BMC Genomics 2011 May 11;12:229. Epub 2011 May 11.

Department of Vertebrate Genomics, Max-Planck-Institute for Molecular Genetics, Berlin, Germany.

Background: Down syndrome (DS; trisomy 21) is the most common genetic cause of mental retardation in the human population and key molecular networks dysregulated in DS are still unknown. Many different experimental techniques have been applied to analyse the effects of dosage imbalance at the molecular and phenotypical level, however, currently no integrative approach exists that attempts to extract the common information.

Results: We have performed a statistical meta-analysis from 45 heterogeneous publicly available DS data sets in order to identify consistent dosage effects from these studies. We identified 324 genes with significant genome-wide dosage effects, including well investigated genes like SOD1, APP, RUNX1 and DYRK1A as well as a large proportion of novel genes (N = 62). Furthermore, we characterized these genes using gene ontology, molecular interactions and promoter sequence analysis. In order to judge relevance of the 324 genes for more general cerebral pathologies we used independent publicly available microarry data from brain studies not related with DS and identified a subset of 79 genes with potential impact for neurocognitive processes. All results have been made available through a web server under http://ds-geneminer.molgen.mpg.de/.

Conclusions: Our study represents a comprehensive integrative analysis of heterogeneous data including genome-wide transcript levels in the domain of trisomy 21. The detected dosage effects build a resource for further studies of DS pathology and the development of new therapies.

Download full-text PDF

Source
http://core.kmi.open.ac.uk/download/pdf/5696938.pdf
Web Search
http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2
Publisher Site
http://dx.doi.org/10.1186/1471-2164-12-229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110572PMC
May 2011
23 Reads

Publication Analysis

Top Keywords

dosage effects
16
studies identified
8
324 genes
8
meta-analysis heterogeneous
8
genome-wide dosage
8
genes
6
effects
5
dosage
5
characterized genes
4
genes gene
4
gene ontology
4
genes characterized
4
novel genes
4
well large
4
large proportion
4
proportion novel
4
relevance 324
4
judge relevance
4
ontology molecular
4
promoter sequence
4

References

(Supplied by CrossRef)

D Patterson et al.
Ment Retard Dev Disabil Res Rev 2007

SE Antonarakis et al.
Trends Mol Med 2006

M Rachidi et al.
Neurosci Res 2007

Y Gitton et al.
Nature 2002

C Canzonetta et al.
Am J Hum Genet 2008

HE Lockstone et al.
Genomics 2007

SE Antonarakis et al.
Nat Rev Genet 2004

FK Wiseman et al.
Hum Mol Genet 2009

P Kahlem et al.
Genome Res 2004

E Aït Yahya-Graison et al.
Am J Hum Genet 2007

CY Chou et al.
Mamm Genome 2008

Similar Publications